| Dr Charles Edwin Newman Jr, MD | |
|
444 N Mills Ave, Orlando, FL 32803-5736 | |
| (407) 481-9505 | |
| (407) 481-9506 |
| Full Name | Dr Charles Edwin Newman Jr |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 17 Years |
| Location | 444 N Mills Ave, Orlando, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629194618 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | ME98267 (Florida) | Primary |
| 208200000X | Plastic Surgery | 104466 (North Carolina) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Orlando | Orlando, FL | Hospital |
| Entity Name | Florida Hospital Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225034234 PECOS PAC ID: 0749186153 Enrollment ID: O20031208000807 |
News Archive
An international team of researchers led by Carnegie Mellon University's Manojkumar Puthenveedu has discovered the mechanism by which signaling receptors recycle, a critical piece in understanding signaling receptor function. Writing in the journal Cell, the team for the first time describes how a signaling receptor travels back to the cell membrane after it has been activated and internalized.
Alcon, Inc. announced today that its board of directors approved a merger agreement with Novartis AG, whereby Novartis will pay a total merger consideration valued at $168 per share for the Alcon shares it does not currently own. Under the terms of the deal, the merger consideration will be comprised of a combination of Novartis shares and, if necessary, a cash contingent value amount to result in a total value of $168 per share.
Treatments for a rare retinal disease may be on the horizon after a new study has identified gene variants that cause a metabolic deficiency in the eye.
Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial with ODM-201, an investigational oral androgen receptor inhibitor in clinical development.
› Verified 1 days ago
| Entity Name | Charles E Newman Jr Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780897959 PECOS PAC ID: 6204923121 Enrollment ID: O20071024000535 |
News Archive
An international team of researchers led by Carnegie Mellon University's Manojkumar Puthenveedu has discovered the mechanism by which signaling receptors recycle, a critical piece in understanding signaling receptor function. Writing in the journal Cell, the team for the first time describes how a signaling receptor travels back to the cell membrane after it has been activated and internalized.
Alcon, Inc. announced today that its board of directors approved a merger agreement with Novartis AG, whereby Novartis will pay a total merger consideration valued at $168 per share for the Alcon shares it does not currently own. Under the terms of the deal, the merger consideration will be comprised of a combination of Novartis shares and, if necessary, a cash contingent value amount to result in a total value of $168 per share.
Treatments for a rare retinal disease may be on the horizon after a new study has identified gene variants that cause a metabolic deficiency in the eye.
Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial with ODM-201, an investigational oral androgen receptor inhibitor in clinical development.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles Edwin Newman Jr, MD 444 N Mills Ave, Orlando, FL 32803-5736 Ph: (407) 481-9505 | Dr Charles Edwin Newman Jr, MD 444 N Mills Ave, Orlando, FL 32803-5736 Ph: (407) 481-9505 |
News Archive
An international team of researchers led by Carnegie Mellon University's Manojkumar Puthenveedu has discovered the mechanism by which signaling receptors recycle, a critical piece in understanding signaling receptor function. Writing in the journal Cell, the team for the first time describes how a signaling receptor travels back to the cell membrane after it has been activated and internalized.
Alcon, Inc. announced today that its board of directors approved a merger agreement with Novartis AG, whereby Novartis will pay a total merger consideration valued at $168 per share for the Alcon shares it does not currently own. Under the terms of the deal, the merger consideration will be comprised of a combination of Novartis shares and, if necessary, a cash contingent value amount to result in a total value of $168 per share.
Treatments for a rare retinal disease may be on the horizon after a new study has identified gene variants that cause a metabolic deficiency in the eye.
Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial with ODM-201, an investigational oral androgen receptor inhibitor in clinical development.
› Verified 1 days ago
Dr. Christopher Dean Prevel, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 5979 Vineland Rd, Suite 114, Orlando, FL 32819 Phone: 407-352-1818 Fax: 407-352-1814 | |
Dr. Kenrick Anthony Spence I, M.D., F.A.C.S. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 130 Hillcrest St, Orlando, FL 32801 Phone: 407-999-2585 Fax: 407-999-2628 | |
Dr. Luis Alejandro Jaramillo, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 14050 Town Loop Blvd, Suite 204, Orlando, FL 32837 Phone: 407-251-8800 | |
Dr. Angelo Alberto Leto Barone, Plastic Surgery Medicare: Medicare Enrolled Practice Location: 6535 Nemours Pkwy, Orlando, FL 32827 Phone: 407-567-4000 Fax: 407-567-5924 | |
Dr. Jerry Alan Rubin, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6900 Turkey Lake Rd, Suite 1-7, Orlando, FL 32819 Phone: 321-939-3300 Fax: 321-939-3303 | |
Dr. Florencio Jorge Gonzalez, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3100 Clay Ave, Suite # 299, Orlando, FL 32804 Phone: 407-447-1628 | |
Dr. Omar E Beidas, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 265 E Rollins St Ste 5300, Orlando, FL 32804 Phone: 407-821-3555 Fax: 407-821-3556 |